Piermont Capital Management Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$425,000
+11.0%
7,100
-15.2%
0.13%
+1.6%
Q1 2018$383,000
-1.5%
8,370
-14.2%
0.13%0.0%
Q4 2017$389,000
-5.6%
9,760
-5.2%
0.13%
-5.9%
Q3 2017$412,000
-54.9%
10,290
-51.5%
0.14%
-47.9%
Q2 2017$914,000
-6.3%
21,214
-31.9%
0.26%
+12.5%
Q1 2017$975,000
+24.0%
31,1410.0%0.23%
+28.9%
Q4 2016$786,000
+0.1%
31,141
-1.9%
0.18%
-3.2%
Q3 2016$785,000
-43.2%
31,741
-53.2%
0.19%
-48.0%
Q2 2016$1,383,000
+158.0%
67,881
+93.3%
0.36%
+109.4%
Q1 2016$536,000
+18.1%
35,125
+4.0%
0.17%
+18.8%
Q4 2015$454,000
-10.3%
33,790
-6.3%
0.14%
-12.7%
Q3 2015$506,000
-51.2%
36,060
-40.9%
0.16%
-47.3%
Q2 2015$1,036,000
+40.6%
60,9900.0%0.31%
+39.7%
Q1 2015$737,000
+120.0%
60,990
+51.0%
0.22%
+88.2%
Q4 2014$335,00040,3800.12%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders